1,432
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia

ORCID Icon, ORCID Icon & ORCID Icon
 

Acknowledgments

The authors wish to acknowledge J Collins (ICCC Rhein-Main, Germany) for writing and editorial assistance.

Declaration of interest

A Aksan has received research funding, consulting and congress fees from Immundiagnostik AG and Vifor.

J Stein has received consulting fees from Pharmacosmos, Vifor, Abbvie, Bristol Myers Squibb, Dr Schar, Falk, Ferring, Fresenius Kabi, Immundiagnostik, Janssen Medice, MSD, Pfizer, Shire, Takeda, Thermofisher; is a Board member for Pharmacosmos, Vifor, Abbvie, Bristol Myers Squibb, Dr Schar, Ferring, Fresenius Kabi, Immundiagnostik, Janssen, MSD, NPS, Takeda, Shield; and receives Lecturing fees from Vifor.

A Dignass has received consulting fees from Abbott, Amgen, Fresenius Kabi, Hexal, Gilead, Galapagos, Pharmacosmos, Vifor, MSD, Ferring, Tillotts, Janssen, Pfizer, Roche/Genentech, Takeda, Falk; receives Lecturing fees from Falk, Ferring, Amgen, MSD, Abbott, Janssen, Pfizer, Pharmacosmos, Vifor, Kompetenznetz CED, Takeda, Tillotts; is involved in manuscript preparations for Falk, Tillotts, Janssen, Pfizer; involved in educational presentations for Pharmacosmos, Falk and Ferring.

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.